DGX vs WFC · P/E 22, rev $5.94B vs P/E 15, rev $22.62B
Quest Diagnostics Incorporated (DGX) versus Wells Fargo & Company (WFC) — a side-by-side from cached financials, not a winner call.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
Wells Fargo & Company (WFC) is a banks - diversified company listed on US. It is led by Charlie Scharf.
Latest reported DGX revenue for 2026-06-30 was $5.94B. Net income was $572.0M. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
Latest reported WFC revenue for 2026-06-30 was $22.62B. Net income was $6.41B. Revenue was up 5.5% from 2026-03-31 to 2026-06-30. WFC currently screens at market cap $272.05B and trailing P/E 15.0.
DGX currently screens at market cap $19.94B and trailing P/E 22.4. WFC currently screens at market cap $272.05B and trailing P/E 15.0.
Not investment advice. Open the DGX and WFC stock pages for the full models.
Not investment advice.